"DiffMaster will be an important part of our continuous work towards increased quality and standardization", comments Per Simonsson, Head of Clinical Chemistry, University Hospital MAS in Malmö.
The laboratory will become a strategic partner to CellaVision, concerning further developments of the system.
"This is a great break-through for us", says Yvonne Mårtensson, CEO at CellaVision, " the first installations will become important references in our launching process.